title: NBOMe designer drug exposures reported to Texas poison centers.
abstract: Use of 2-methoxybenzyl analogues of 2C-X phenethylamines (NBOMe) is increasing in the United States. Twenty-five NBOMe exposures reported to Texas poison centers during 2012-2013 were identified; 76% involved 25I-NBOMe, 12% involved 25C-NBOMe, and 12% involved an unknown NBOMe. Eighty-eight percent of the patients were men; mean age was 17 years (range, 14-25 years). The exposure route was 72% from ingestion alone, 12% from inhalation alone, 4% from ingestion and inhalation, and 12% from an unknown route. The most common clinical effects were tachycardia (52%), agitation (48%), hallucinations (32%), hypertension (32%), confusion (24%), and mydriasis (20%). Two patients died.
authors.affiliation: a Texas Department of State Health Services , Austin , Texas , USA.
authors.forename: Mathias B
authors.initials: MB
authors.lastname: Forrester
mesh_terms: D000293:Adolescent; D000328:Adult; D015198:Designer Drugs / Q000506:poisoning*; D004118:Dimethoxyphenylethylamine / Q000031:analogs & derivatives* / Q000506:poisoning; D006801:Humans; D008297:Male; D011039:Poison Control Centers / Q000706:statistics & numerical data; D019966:Substance-Related Disorders / Q000453:epidemiology; D013781:Texas / Q000453:epidemiology; D055815:Young Adult
chemical_list: D015198:Designer Drugs; D004118:Dimethoxyphenylethylamine; C554181:2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
keywords: 25C-NBOMe; 25I-NBOMe; NBOMe; designer drug; poison center